Notable Mergers and Acquisitions of the Day 2/18: GPCB
- GPC Biotech AG (NASDAQ: GPCB) and Agennix announced that the two oncology-focused biotechnology companies have signed a Business Combination Agreement under which they propose to merge their businesses.
In the transaction, GPC Biotech is to be merged onto a new German company, which will hold all of the shares of Agennix and a €15 million cash contribution by dievini Hopp BioTech holding GmbH & Co KG, an investment company of Dietmar Hopp, co-founder of SAP, and one of the largest shareholders of GPC Biotech.
The agreement assumes a merger ratio resulting in an economic ownership in the new company as follows: Agennix shareholders (approximately 48.0%), GPC Biotech shareholders (approximately 39.3%), and approximately 12.7% being attributed to the capital increase by dievini Hopp BioTech holding.
You May Also Be Interested In
- Pre-Open Movers 5/23: (PETM) (RA) (GES) Higher; (DELL) (BIG) (MS) Lower (more...)
- Streetinsider.com's Hot Lunchtime Reads 05/23: (FB) (FIO) (CREE) (SODA) (JCP) (RL)
- Streetinsider.com's Hot Lunchtime Reads 05/22: (FMCN) (RF) (FB) (JPM) (CHK) (DRYS)
Create E-mail Alert Related Categories
Special ReportsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
